Vitespen Completed Phase 1 Trials for Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00003025Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer